Literature DB >> 25503552

One, two, three steps toward cell therapy for stroke.

Theo Diamandis1, Cesar V Borlongan2.   

Abstract

Entities:  

Keywords:  standards; stem cells; stroke; therapy

Mesh：

Year:  2014        PMID： 25503552      PMCID： PMC4354885          DOI： 10.1161/STROKEAHA.114.007105

Source DB:  PubMed          Journal:  Stroke        ISSN： 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  28 in total

1.  Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI.

Authors:  Raphael Guzman; Nobuko Uchida; Tonya M Bliss; Dongping He; Karen K Christopherson; David Stellwagen; Alexandra Capela; Joan Greve; Robert C Malenka; Michael E Moseley; Theo D Palmer; Gary K Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-06       Impact factor: 11.205

Review 2.  Cell-based therapy in ischemic stroke.

Authors:  David C Hess; Cesar V Borlongan
Journal:  Expert Rev Neurother       Date:  2008-08       Impact factor: 4.618

3.  Intravenous route of cell delivery for treatment of neurological disorders: a meta-analysis of preclinical results.

Authors:  Miroslaw Janowski; Piotr Walczak; Isao Date
Journal:  Stem Cells Dev       Date:  2010-01       Impact factor: 3.272

Review 4.  Baby STEPS: a giant leap for cell therapy in neonatal brain injury.

Authors:  Cesar V Borlongan; Michael D Weiss
Journal:  Pediatr Res       Date:  2011-07       Impact factor: 3.756

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors.

Authors:  Christine Seminatore; Jerome Polentes; Ditte Ellman; Nataliya Kozubenko; Valerie Itier; Samir Tine; Laurent Tritschler; Marion Brenot; Emmanuelle Guidou; Johanna Blondeau; Mickael Lhuillier; Aurore Bugi; Laetitia Aubry; Pavla Jendelova; Eva Sykova; Anselme L Perrier; Bente Finsen; Brigitte Onteniente
Journal:  Stroke       Date:  2009-11-25       Impact factor: 7.914

Review 7.  Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke.

Authors: 
Journal:  Stroke       Date:  2008-12-18       Impact factor: 7.914

8.  The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion.

Authors:  Paul Stroemer; Sara Patel; Andrew Hope; Cathy Oliveira; Kenny Pollock; John Sinden
Journal:  Neurorehabil Neural Repair       Date:  2009-07-24       Impact factor: 3.919

9.  Who's in favor of translational cell therapy for stroke: STEPS forward please?

Authors:  Michael Chopp; Gary K Steinberg; Douglas Kondziolka; Mei Lu; Tonya M Bliss; Yi Li; David C Hess; Cesario V Borlongan
Journal:  Cell Transplant       Date:  2009-09-28       Impact factor: 4.064

10.  Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke: experience from Australian stroke center.

Authors:  Sharman P Tan Tanny; Lucy Busija; Danny Liew; Sarah Teo; Stephen M Davis; Bernard Yan
Journal:  Stroke       Date:  2013-06-18       Impact factor: 7.914
View more
  24 in total

1.  Preliminary Reports of Stereotaxic Stem Cell Transplants in Chronic Stroke Patients.

Authors:  Cesar V Borlongan
Journal:  Mol Ther       Date:  2016-10       Impact factor: 11.454

Review 2.  Stem Cell Recipes of Bone Marrow and Fish: Just What the Stroke Doctors Ordered.

Authors:  Eleonora Napoli; Cesar V Borlongan
Journal:  Stem Cell Rev Rep       Date:  2017-04       Impact factor: 5.739

3.  The brain and eye: Treating cerebral and retinal ischemia through mitochondrial transfer.

Authors:  Matt Heyck; Brooke Bonsack; Henry Zhang; Nadia Sadanandan; Blaise Cozene; Chase Kingsbury; Jea-Young Lee; Cesar V Borlongan
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-11

Review 4.  Optimizing functional outcome endpoints for stroke recovery studies.

Authors:  Mustafa Balkaya; Sunghee Cho
Journal:  J Cereb Blood Flow Metab       Date:  2019-09-14       Impact factor: 6.200

Review 5.  Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms.

Authors:  Connor Stonesifer; Sydney Corey; Shaila Ghanekar; Zachary Diamandis; Sandra A Acosta; Cesar V Borlongan
Journal:  Prog Neurobiol       Date:  2017-07-23       Impact factor: 11.685

6.  Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke.

Authors:  Michael G Liska; Marci G Crowley; Cesar V Borlongan
Journal:  Transl Stroke Res       Date:  2017-01-26       Impact factor: 6.829

7.  Fibroblast Growth Factor Type 1 (FGF1)-Overexpressed Adipose-Derived Mesenchaymal Stem Cells (AD-MSCFGF1) Induce Neuroprotection and Functional Recovery in a Rat Stroke Model.

Authors:  Hamed Ghazavi; Seyed Javad Hoseini; Alireza Ebrahimzadeh-Bideskan; Baratali Mashkani; Soghra Mehri; Ahmad Ghorbani; Kayvan Sadri; Elahe Mahdipour; Faezeh Ghasemi; Fatemeh Forouzanfar; Azar Hoseini; Ali Reza Pasdar; Hamid Reza Sadeghnia; Majid Ghayour-Mobarhan
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

8.  The future of stem cell therapy for stroke rehabilitation.

Authors:  Cesar V Borlongan; Jukka Jolkkonen; Olivier Detante
Journal:  Future Neurol       Date:  2015-08

Review 9.  Translational Hurdles in Stroke Recovery Studies.

Authors:  Jukka Jolkkonen; Gert Kwakkel
Journal:  Transl Stroke Res       Date:  2016-03-22       Impact factor: 6.829

10.  Recent Advances in Stem Cell-Based Therapeutics for Stroke.

Authors:  Eleonora Napoli; Cesar V Borlongan
Journal:  Transl Stroke Res       Date:  2016-08-12       Impact factor: 6.829
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.